Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis

• Published in: Clinica chimica acta Vol. 359; no. 1; pp. 72 - 77
• Main Authors: van Toorenenbergen, A.W., Oranje, A.P.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2005
• Subjects: Humans; Mastocytosis; Mastocytosis - blood; Mastocytosis - urine; Methylhistamines - urine; N-methylhistamine; Reproducibility of Results; Serine Endopeptidases - blood; Tryptase; Tryptases; Mastocytosis; N-methylhistamine; Tryptase
• ISSN: 0009-8981; 1873-3492
• DOI: 10.1016/j.cccn.2005.03.041

The disease extent of mastocytosis can be assessed by measurement of mediators or their metabolites, secreted from mast cells. In the present study, we compared results of urinary N-methylhistamine measurements with analysis of total tryptase in serum from patients with suspected mastocytosis. Tryptase in serum was determined with the UniCAP tryptase fluor-enzyme-immunoassay, according to the manufacturers' instructions (Pharmacia, Woerden, Netherlands). N-methylhistamine in urine was determined by competitive radioimmunoassay, according to the manufacturers' instructions (Pharmacia). A significant correlation between serum tryptase and urine N-methylhistamine was found both for 138 patients aged 14 or older (Spearman Rank r s = 0.43, p < 0.0001) and for 23 younger patients (Spearman Rank r s = 0.46, p = 0.0267). The between-run coefficient of variation of the tryptase assay was half (6.7%) of the one (13%) found with the urinary N-methylhistamine assay. Both for urine N-methylhistamine and serum tryptase, a significant difference was found between corresponding biopsies with an increased number of mast cell aggregates and biopsies without such an increase. The difference between tryptase levels however was stronger (Mann–Whitney: p = 0.0012) than the difference between N-methylhistamine levels (Mann–Whitney: p = 0.0140). Serum tryptase discriminates better than urinary N-methylhistamine between patients with an increased number of mast cell aggregates and persons without such an increase.